Difference between revisions of "Covid-19" English (en) français (fr)

From thinktank

Jump to: navigation, search
(Institutions)
(External)
Line 33: Line 33:
 
* PubMed.gov, [https://www.ncbi.nlm.nih.gov/pubmed/32035997 Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents], by Kampf G, Todt D, Pfaender S, Steinmann E, in The Journal of public infection, 2020, https://doi.org/10.1016/j.jhin.2020.01.022
 
* PubMed.gov, [https://www.ncbi.nlm.nih.gov/pubmed/32035997 Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents], by Kampf G, Todt D, Pfaender S, Steinmann E, in The Journal of public infection, 2020, https://doi.org/10.1016/j.jhin.2020.01.022
 
* Methods for estimating the case fatality ratio for a novel, emerging infectious disease. ''During the course of an epidemic of a potentially fatal disease, it is important that the case fatality ratio be well estimated...'', A. C. Ghani, C. A. Donnelly, D. R. Cox, J. T. Griffin, C. Fraser, T. H. Lam, L. M. Ho, W. S. Chan, R. M. Anderson, A. J. Hedley, G. M. Leung, American Journal of Epidemiology, Volume 162, Issue 5, 1 September 2005, Pages 479–486, https://doi.org/10.1093/aje/kwi230
 
* Methods for estimating the case fatality ratio for a novel, emerging infectious disease. ''During the course of an epidemic of a potentially fatal disease, it is important that the case fatality ratio be well estimated...'', A. C. Ghani, C. A. Donnelly, D. R. Cox, J. T. Griffin, C. Fraser, T. H. Lam, L. M. Ho, W. S. Chan, R. M. Anderson, A. J. Hedley, G. M. Leung, American Journal of Epidemiology, Volume 162, Issue 5, 1 September 2005, Pages 479–486, https://doi.org/10.1093/aje/kwi230
 +
====EUR-Lex====
 +
* {{Celex|52020DC0112}}, Communication from the Commission to the European Parliament, the European Council, the Council, the European Central Bank, the European Investment Bank and the Eurogroup - ''Coordinated economic response to the covid-19 outbreak'', Brussels, 13 March 2020.
 
{{Acronym}}
 
{{Acronym}}
 
{{Ref}}
 
{{Ref}}
 
[[Category:Health]]
 
[[Category:Health]]

Revision as of 16:48, 18 March 2020

Covid-19 stands for the Coronavirus (nCoV) disease 2019.

On 12 February 2020, the novel coronavirus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) while the disease associated with it is now referred to as covid-19.[1]

See also

External

Institutions

Maps and dashboards

Data

News

Studies

EUR-Lex

  • Eur-Lex:52020DC0112, Communication from the Commission to the European Parliament, the European Council, the Council, the European Central Bank, the European Investment Bank and the Eurogroup - Coordinated economic response to the covid-19 outbreak, Brussels, 13 March 2020.

Other definitions

Search other definitions of Covid-19 with

EN FR ES
AcronymFinder.com (en) sigles.net (fr) siglas.com (es)
AllAcronyms.com (en) AbbreviationFinder.org (fr) AbbreviationFinder.org (es)
EuroVoc (en) EuroVoc (fr) EuroVoc (es)
FT's Lexicon (en)
IATE (en) IATE (fr) IATE (es)
Investopedia (en)
Oxford Dictionaries (en)
Reuters Financial Glossary (en)
Wikipedia (en) Wikipedia (fr) Wikipedia (es)


References

  1. ECDC, Threats and outbreaks, Covid-19, last retrieved on 5 March 2020.
Personal tools